Oramed to Present at H.C. Wainwright 24th Annual Global Investment Conference
- Tuesday, September 6, 2022, 7:10
- PR Newswire
- Add a comment
NEW YORK, Sept. 6, 2022 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Chief Executive Officer Nadav Kidron will present an…
About the Author
admin has written 20652 stories on this site.